,
,
, lOMoAR i cPSD|
i 21007614
lOMoAR i cPSD| i 21007614
Chapter 1 Issues for the Practitioner in Drug Therapy
i i i i i i i i
MULTIPLE iCHOICE
1. Nurse ipractitioner iprescriptive iauthority iis iregulated iby:
A. The iNational iCouncil iof iState iBoards iof iNursing
B. The iU.S. iDrug iEnforcement iAdministration
C. The iState iBoard iof iNursing ifor ieach istate
D. The iState iBoard iof iPharmacy
ANS: i C PTS: i 1
2. Physician iAssistant i(PA) iprescriptive iauthority iis iregulated iby:
A. The iNational iCouncil iof iState iBoards iof iNursing
B. The iU.S. iDrug iEnforcement iAdministration
C. The iState iBoard iof iNursing
D. The iState iBoard iof iMedical iExaminers
ANS: i D PTS: i 1
3. Clinical ijudgment iin iprescribing iincludes:
A. Factoring iin ithe icost ito ithe ipatient iof ithe imedication iprescribed
B. Always iprescribing ithe inewest imedication iavailable ifor ithe idisease iprocess
C. Handing iout idrug isamples ito ipoor ipatients
D. Prescribing iall igeneric imedications ito icut icosts
ANS: i A PTS: i 1
4. Criteria ifor ichoosing ian ieffective idrug ifor ia idisorder iinclude:
A. Asking ithe ipatient iwhat idrug ithey ithink iwould iwork ibest ifor ithem
B. Consulting inationally irecognized iguidelines ifor idisease imanagement
C. Prescribing imedications ithat iare iavailable ias isamples ibefore iwriting ia iprescription
D. Following iU.S. iDrug iEnforcement iAdministration i(DEA) iguidelines
for iprescribing
i
ANS: i B PTS: i 1
5. Nurse ipractitioner ipractice imay ithrive iunder ihealth-care ireform idue ito:
A. The idemonstrated iability iof inurse ipractitioners ito icontrol icosts iand iimprove
patient ioutcomes
i
B. The ifact ithat inurse ipractitioners iwill ibe iable ito ipractice iindependently
C. The ifact ithat inurse ipractitioners iwill ihave ifull ireimbursement iunder ihealth-
care ireform
D. The iability ito ishift iaccountability ifor iMedicaid ito ithe istate ilevel
ANS: i A PTS: i 1
,
, lOMoAR i cPSD|
i 21007614
lOMoAR i cPSD| i 21007614
Chapter 1 Issues for the Practitioner in Drug Therapy
i i i i i i i i
MULTIPLE iCHOICE
1. Nurse ipractitioner iprescriptive iauthority iis iregulated iby:
A. The iNational iCouncil iof iState iBoards iof iNursing
B. The iU.S. iDrug iEnforcement iAdministration
C. The iState iBoard iof iNursing ifor ieach istate
D. The iState iBoard iof iPharmacy
ANS: i C PTS: i 1
2. Physician iAssistant i(PA) iprescriptive iauthority iis iregulated iby:
A. The iNational iCouncil iof iState iBoards iof iNursing
B. The iU.S. iDrug iEnforcement iAdministration
C. The iState iBoard iof iNursing
D. The iState iBoard iof iMedical iExaminers
ANS: i D PTS: i 1
3. Clinical ijudgment iin iprescribing iincludes:
A. Factoring iin ithe icost ito ithe ipatient iof ithe imedication iprescribed
B. Always iprescribing ithe inewest imedication iavailable ifor ithe idisease iprocess
C. Handing iout idrug isamples ito ipoor ipatients
D. Prescribing iall igeneric imedications ito icut icosts
ANS: i A PTS: i 1
4. Criteria ifor ichoosing ian ieffective idrug ifor ia idisorder iinclude:
A. Asking ithe ipatient iwhat idrug ithey ithink iwould iwork ibest ifor ithem
B. Consulting inationally irecognized iguidelines ifor idisease imanagement
C. Prescribing imedications ithat iare iavailable ias isamples ibefore iwriting ia iprescription
D. Following iU.S. iDrug iEnforcement iAdministration i(DEA) iguidelines
for iprescribing
i
ANS: i B PTS: i 1
5. Nurse ipractitioner ipractice imay ithrive iunder ihealth-care ireform idue ito:
A. The idemonstrated iability iof inurse ipractitioners ito icontrol icosts iand iimprove
patient ioutcomes
i
B. The ifact ithat inurse ipractitioners iwill ibe iable ito ipractice iindependently
C. The ifact ithat inurse ipractitioners iwill ihave ifull ireimbursement iunder ihealth-
care ireform
D. The iability ito ishift iaccountability ifor iMedicaid ito ithe istate ilevel
ANS: i A PTS: i 1
